STSN Stock Overview
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Stemsation International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.02 |
| 52 Week High | US$0.069 |
| 52 Week Low | US$0.0041 |
| Beta | 0 |
| 1 Month Change | -30.18% |
| 3 Month Change | 121.11% |
| 1 Year Change | 165.33% |
| 3 Year Change | -37.81% |
| 5 Year Change | -60.20% |
| Change since IPO | -94.31% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| STSN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -0.5% | -3.6% | -0.7% |
| 1Y | 165.3% | -29.3% | 22.3% |
Return vs Industry: STSN exceeded the US Personal Products industry which returned -29.3% over the past year.
Return vs Market: STSN exceeded the US Market which returned 22.3% over the past year.
Price Volatility
| STSN volatility | |
|---|---|
| STSN Average Weekly Movement | 70.9% |
| Personal Products Industry Average Movement | 9.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: STSN's share price has been volatile over the past 3 months.
Volatility Over Time: STSN's weekly volatility has increased from 54% to 71% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ray Carter | www.stemsation.global |
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration. The company sells its products through independent wellness advocates directly to consumers.
Stemsation International, Inc. Fundamentals Summary
| STSN fundamental statistics | |
|---|---|
| Market cap | US$5.22m |
| Earnings (TTM) | -US$52.74k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs STSN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STSN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$52.74k |
| Earnings | -US$52.74k |
Last Reported Earnings
Jun 30, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did STSN perform over the long term?
See historical performance and comparison